Inducible Nitric Oxide Synthase Binds, S-Nitrosylates, and Activates Cyclooxygenase-2.
Kim, S.F., Huri, D.A. and Snyder, S.H. Science, 310, 1966-1970 (December 23, 2005).
Solomon Snyder’s laboratory has built upon earlier work showing that prostaglandin production is altered by stimulants and inhibitors to inducible nitric oxide synthase (iNOS). The new data reveal that nitrosylation activates cyclooxygenase-2 (COX-2) by increasing the apparent Vmax without altering the enzyme’s affinity for its substrate, arachidonic acid. The enzyme may be nitrosylated at many of its 13 cysteine residues, but its activation is associated specifically with nitrosylation at cysteine-526. Moreover, the nitrosylation process involves a binding of iNOS with COX-2, as the two enzymes coprecipitate with an antibody to COX-2. The binding is not dependent upon their respective enzymatic activities, as inhibitors had no effect on their coimmunoprecipitation. Moreover, expression of a COX-2 fragment (484-604), which binds to iNOS, blocks prostaglandin E2 (PGE2) formation in macrophages exposed to an inflammatory stimulus, lipopolysaccharide plus gamma-interferon. Macrophages from iNOS knockout mice provided confirmatory evidence, showing a 70% lower response, as measured by PGE2 formation, to the stimulus.
The results suggest that synergism between the nitric oxide- and prostaglandin-mediated inflammatory pathways hinges on the binding of iNOS to COX-2. Hence, creation of inhibitors to iNOS that block both this enzyme’s activity and its binding to COX-2 may prove highly effective in treating inflammatory diseases.
Message posted by: Keith Markey
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...